EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Confidence in Managing Use and Minimising Harm as Mediators of Quality of Life among Anabolic-Androgenic Steroid Consumers in Alcohol and Other Drug Treatment Settings

Benjamin Bonenti, Nicholas Leigh Kerswell, Grace Shuttleworth, Carmen Lim, Thomas O'Connor, Jason Ferris, Kylie Lee, Timothy Piatkowski

European Addiction Research · 2026

DOI: 10.1159/000550427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Addiction Research, 2026. Verfasst von Benjamin Bonenti und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Applied Psychology and Griffith Centre for Mental Health, Griffith University, Brisbane, Queensland, Australia, b.bonenti@griffith.edu.au. Hauptthemen laut MEDLINE: Quality of Life, Substance-Related Disorders, Harm Reduction, Anabolic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Anabolic-androgenic steroid (AAS) consumers frequently experience elevated physical and psychological risks, yet the psychological mechanisms linking risk exposure to health outcomes remain poorly understood. This study examined whether general confidence in managing substance use and minimising harm mediates the relationship between clinical risk and quality of life among AAS consumers engaged with community-based alcohol and other drug (AOD) services.

Methods

Intake data from 517 adults (93.4% male) reporting lifetime AAS use were analysed, drawn from a broader cohort of 18,786 clients at Lives Lived Well services between 2020 and 2024. Mediation analyses tested whether two confidence variables: (1) substance use management and (2) harm minimisation, explained associations between clinical risk (defined by World Health Organisation – Alcohol, Smoking and Substance Involvement Screening Test steroid risk score), and three quality of life domains: physical, psychological, and overall wellbeing.

Results

Higher clinical steroid risk scores were significantly associated with poorer quality of life across domains; however, these effects were fully mediated by lower general confidence in managing substance use and minimising harm among clients who reported AAS use. Confidence in consumption practices buffered against physical undesired effects, while confidence in harm reduction was strongly linked to psychological wellbeing.

Conclusions

Among AAS consumers in AOD treatment, broader substance use confidence appears meaningfully related to quality of life. While the confidence measures are general rather than AAS-specific, these findings provide a preliminary insight into confidence-related processes in a clinically underexamined group. Interventions that promote these strategies may offer a critical mechanism for ensuring this cohort physical and psychological wellbeing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeSubstance-Related DisordersHarm ReductionAnabolic AgentsHumansMaleAdultAnabolic Androgenic SteroidsFemaleMiddle AgedYoung Adult

Stichwörter der Autor:innen

Anabolic-androgenic steroidsClinical riskConfidenceHarm reductionHealth educationHealth literacyQuality of life

Substanzen

Anabolic Androgenic SteroidsAnabolic Agents

Autor:innen und Institutionen

  • School of Applied Psychology and Griffith Centre for Mental Health, Griffith University, Brisbane, Queensland, Australia, b.bonenti@griffith.edu.au.
  • Centre for Health Services Research, University of Queensland, Brisbane, Queensland, Australia, b.bonenti@griffith.edu.au.
  • Lives Lived Well, Brisbane, Queensland, Australia.
  • School of Psychology, University of Queensland, Brisbane, Queensland, Australia.
  • National Centre for Youth Substance Use, University of Queensland, Brisbane, Queensland, Australia.
  • Department of Internal Medicine, University of Connecticut School of Medicine, Farmington, Connecticut, USA.

Zitieren

APA

Bonenti, B., Kerswell, N. L., Shuttleworth, G., Lim, C., O'Connor, T., Ferris, J., Lee, K., & Piatkowski, T. (2026). Confidence in Managing Use and Minimising Harm as Mediators of Quality of Life among Anabolic-Androgenic Steroid Consumers in Alcohol and Other Drug Treatment Settings. European Addiction Research. https://doi.org/10.1159/000550427

Vancouver

Bonenti B, Kerswell NL, Shuttleworth G, Lim C, O'Connor T, Ferris J, et al. Confidence in Managing Use and Minimising Harm as Mediators of Quality of Life among Anabolic-Androgenic Steroid Consumers in Alcohol and Other Drug Treatment Settings. European Addiction Research. 2026. doi:10.1159/000550427

BibTeX
@article{Bonenti2026,
  author = {Bonenti, Benjamin and Kerswell, Nicholas Leigh and Shuttleworth, Grace and Lim, Carmen and O'Connor, Thomas and Ferris, Jason and Lee, Kylie and Piatkowski, Timothy},
  title = {Confidence in Managing Use and Minimising Harm as Mediators of Quality of Life among Anabolic-Androgenic Steroid Consumers in Alcohol and Other Drug Treatment Settings},
  journal = {European Addiction Research},
  year = {2026},
  doi = {10.1159/000550427}
}
Kostenlos starten →